Life POD Research Library
Quick-reference sheet — all compounds from Life Peptides LLC — Life Peptides LLC
lifepod.info · lifepeptides.info
For Research Use Only
| Peptide | Dose | Primary Support | Mechanism | Best Stacks | Purpose |
|---|---|---|---|---|---|
| BPC-157 | 10 mg | Tissue repairGut health | Nitric oxide modulation · GH receptor upregulation · VEGF / angiogenesis | BPC-157 + TB-500 | Soft tissue healing, GI mucosal repair, tendon-to-bone healing, anti-inflammatory |
| TB-500 | 10 mg | Systemic recoveryTissue repair | Thymosin Beta-4 analogue · Actin upregulation · Cell migration to injury sites | BPC-157 + TB-500 | Whole-body recovery, muscle & tendon healing, cardiac & neurological repair |
| BPC-157 + TB-500 Stack | 10 mg / 10 mg | Synergistic healing | Complementary pathways: local tissue environment (BPC-157) + systemic cell migration (TB-500) | Pre-combined stack | Accelerated soft tissue repair — preclinical data suggests 30–40% improvement vs. monotherapy |
| CJC-1295 No DAC | 10 mg | Growth hormone release | GHRH analogue · Pulsatile GH stimulation · ~30 min half-life | CJC-1295 + Ipamorelin | GH axis research, body composition, lean mass, fat metabolism |
| CJC-1295 + Ipamorelin | 10 mg / 10 mg | Synergistic GH release | Dual-pathway: GHRH receptor (CJC) + ghrelin receptor (Ipamorelin) — synergistic GH pulse | Pre-combined stack | GH axis research, body composition, sleep quality, metabolic health |
| Ipamorelin | 10 mg | Selective GH secretagogue | Ghrelin receptor agonist · GH release without cortisol / prolactin elevation · ~2 hr half-life | CJC-1295 + Ipamorelin · Tesamorelin + Ipamorelin | Clean GH stimulation, body composition, bone density, sleep architecture |
| Tesamorelin | 10 mg | Metabolic healthGH axis | Stabilized GHRH analogue · Longer half-life than native GHRH · FDA-approved (Egrifta) | Tesamorelin + Ipamorelin | Visceral fat reduction, GH axis research, metabolic syndrome, cognitive function |
| Tesamorelin + Ipamorelin | 10 mg / 10 mg | Enhanced GH protocol | Dual-pathway GH stimulation with clinically validated GHRH component | Pre-combined stack | Sustained GH axis stimulation, body composition, metabolic research |
| IGF-1 LR3 | 1 mg | Anabolic signallingCell growth | Long-acting IGF-1 analogue · Reduced IGF-BP binding · ~20–30 hr half-life · mTOR activation | Advanced — use with caution | Muscle protein synthesis, cell proliferation, metabolic regulation, growth factor research |
| Tirzepatide | 10 mg | Metabolic healthWeight management | Dual GIP + GLP-1 receptor agonist · FDA-approved (Mounjaro / Zepbound) | Standalone | Obesity research, insulin sensitivity, cardiovascular risk, metabolic disease models |
| SEMAX | 10 mg | NeuroprotectionCognition | ACTH 4-7 fragment · BDNF upregulation · Dopaminergic & serotonergic modulation | NAD+ · Glutathione | Cognitive function, neuroprotection, stroke recovery models, BDNF research |
| MOTS-C | 10 mg | Metabolic regulationLongevity | Mitochondrial-derived peptide · AMPK activation · Insulin sensitivity · Longevity pathways | NAD+ · L-Carnitine | Metabolic homeostasis, exercise capacity, fat metabolism, longevity pathway research |
| GHK-Cu | 100 mg | Skin & wound healing | Copper-binding peptide · Collagen & GAG synthesis · Angiogenesis · Anti-inflammatory | Topical / standalone | Wound healing, skin regeneration, collagen synthesis, hair follicle research |
| NAD+ | 500 mg | Cellular energyLongevity | Coenzyme for energy metabolism · Sirtuin activation · DNA repair · Mitochondrial function | SEMAX · MOTS-C · Glutathione | Cellular energy, DNA repair, ageing biology, metabolic health, sirtuin research |
| Glutathione | 600 mg | AntioxidantImmune function | Master endogenous antioxidant · Phase II detoxification · Oxidative stress management | NAD+ · SEMAX | Oxidative stress, immune function, detoxification, ageing biology |
| L-Carnitine | 600 mg | Fat metabolismMitochondrial health | Mitochondrial fatty acid transport · Beta-oxidation support · Acyl group clearance | MOTS-C · NAD+ | Fat metabolism, mitochondrial function, exercise performance, cardiovascular health |
| KLOW Stack | 10/10/10/50 mg | Multi-pathway protocol | Four-compound formulation targeting multiple biological pathways simultaneously | Pre-combined stack | Multi-pathway research, synergy studies, complex biological system research |
| 3-RTA | 20 mg | Advanced research | Consult Life Peptides documentation for mechanism details | Consult documentation | Specialized laboratory applications — see Life Peptides research documentation |
| BAC Water | 10 ml | Reconstitution medium | 0.9% benzyl alcohol in sterile water — bacteriostatic, multi-dose safe | Required for all lyophilised peptides | Standard reconstitution of lyophilised research peptides. Refrigerate after opening; use within 28–30 days. |
Source: lifepod.info/library/complete-peptide-guide-2027 · Life Peptides LLC
© 2027 Life POD · For research use only · Not medical advice
Life POD is preparing for launch.
Coming soon
We’re building something worth showing up for.